Status:

COMPLETED

Evaluating Genetic Factors That May Contribute to Elastin Function and the Development of Chronic Obstructive Pulmonary Disease

Lead Sponsor:

Washington University School of Medicine

Conditions:

Emphysema

Pulmonary Disease, Chronic Obstructive

Eligibility:

All Genders

18+ years

Brief Summary

Chronic obstructive pulmonary disease (COPD) is a lung disease that is primarily caused by cigarette smoking. The breakdown of elastin, a protein found in the lungs, can cause lung damage and may cont...

Detailed Description

COPD is a disease in which the lung airways are damaged and partly obstructed, making it difficult to breathe. There is no cure for this disease, and it is the fourth leading cause of death in the Uni...

Eligibility Criteria

Inclusion

  • Age equal to or greater than 18 years
  • Ability to read and write in English
  • Able to participate in the informed consent process
  • Acceptable pulmonary function tests (PFTs) done at Barnes-Jewish Hospital within 1 month of study enrollment
  • Relatively stable clinical status (not experiencing COPD exacerbation in the previous 6 weeks)
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) class III or IV COPD (FEV1/FVC less than 70% and FEV1 less than 50% of predicted value)

Exclusion

  • Pregnant
  • Prisoner
  • Vulnerable populations
  • Pi Z phenotype (i.e., alpha-1 antitrypsin deficiency)
  • Significant lung disease, other than COPD / emphysema / chronic bronchitis (e.g., interstitial lung disease, asthma or other predominant airway disease, cystic fibrosis, active tuberculosis)
  • Known active hepatitis B, hepatitis C, or HIV/AIDS (found in medical record review; not prospectively evaluated)
  • Coexisting active chronic inflammatory or collagen vascular disease, immunodeficiency of any kind, non-cutaneous malignancy (melanoma is an exclusion), or previous organ transplant

Key Trial Info

Start Date :

November 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2017

Estimated Enrollment :

255 Patients enrolled

Trial Details

Trial ID

NCT00725309

Start Date

November 1 2007

End Date

December 1 2017

Last Update

June 18 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110